Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SimpleMix: Subject vs Investigator Titration of BIAsp 30 in T2D
NCT01427920Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2011
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 4 trial of biphasic insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Sep 2011; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01427920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427920.